Cary, N.C. – June 13, 2011 – Industry Standard Research (ISR) today announced the availability of its 3rd annual CRO Quality Benchmarking Report. The 2011 version of the report profiles 169 pharmaceutical and biotechnology professionals and their experiences with dozens of small, mid-size, and large CROs. In total, data were collected on over 410 Sponsor / CRO interactions. “We’re operating in an extraordinarily busy and complicated time in the world of drug development,” stated Kevin Olson, CEO, Industry Standard Research. Olson went on: “Drug companies are merging, acquiring, and cutting at seemingly unprecedented rates and outsourcing more and more of their development activities. CROs, for their part, are consolidating at least as fast and need to do everything possible to ensure they stay focused on the quality of their service amidst all the activity. This report provides sponsor companies a critical tool that will maximize their chances of success when selecting a CRO partner. Historically, sponsors have been left to select their CROs based solely on their own experiences and on what the CROs tell them. This “Consumer Reports-style” analysis allows every buyer access to the experience of nearly 200 other drug development professionals worldwide.” The study, in its third consecutive year of publication, segments much of its data by clinical phase of development. In addition to the annual service quality measurements the study also delivers a detailed analysis of CRO selection drivers, outsourcing volume, preferred CROs, intended future use of specific CROs, and much more. The report contains nearly 300 pages with several hundred charts and graphs and insightful analysis not found anywhere else in the industry. Mr. Olson further explains: “It’s been our goal every year with this report to empower sponsors to make more informed outsourcing decisions and to provide CROs with the data they need to compete in an ultra-competitive market. The feedback we receive from our customers suggests the CRO Quality Benchmarking Report does that better than any other resource.” About Industry Standard Research Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise. For more information about our syndicated and custom research offerings, please visit the company’s Web site at www.ISRreports.com or email email@example.com.